People · Operator

Thomas E. Beier

Named in public records as an officer, director or promoter · active 2009–2013 · Pharmaceuticals

1
Companies
2
Filings
$206.0M
Combined raised · real
Single
Operator type
Companies
CompanyRoleSectorStageRaised · realValue · estTied
Opko Health, Inc.PharmaceuticalsSeries D+$206.0M$6.2B2009
Operator network

Thomas E. Beier at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.

Steven D. Rubin · 9 companies · 1 sharedSteven D. RubinJANE H HSIAO · 5 companies · 1 sharedJANE H HSIAORichard A. Lerner · 4 companies · 1 sharedRichard A. LernerRichard C. Pfenniger, Jr. · 4 companies · 1 sharedRichard C. Pfenni…Phillip Frost · 3 companies · 1 sharedPhillip FrostAlice Lin-Tsing C. Yu · 1 companies · 1 sharedAlice Lin-Tsing C…Alice Lin-Tsing Yu · 1 companies · 1 sharedAlice Lin-Tsing YuDmitry A. Kolosov · 1 companies · 1 sharedDmitry A. KolosovJohn A. Paganelli · 1 companies · 1 sharedJohn A. PaganelliJuan F. Rodriguez · 1 companies · 1 sharedJuan F. RodriguezNaveed K Shams · 1 companies · 1 sharedNaveed K ShamsPascal J. Goldschmidt · 1 companies · 1 sharedPascal J. Goldsch…Rao Uppaluri · 1 companies · 1 sharedRao UppaluriRobert A. Baron · 1 companies · 1 sharedRobert A. BaronOpko Health, Inc. · $206.0M raisedOpko Health, Inc.Thomas E. BeierTB
Thomas E. Beier Company Co-operator (ring = serial)Hover to isolate ties · click to open
Co-operators (shared boards)

People named alongside Thomas E. Beier on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.

OperatorSharedTheir companies
Steven D. Rubin19
JANE H HSIAO15
Richard C. Pfenniger, Jr.14
Richard A. Lerner14
Phillip Frost13
Dmitry A. Kolosov11
Pascal J. Goldschmidt11
Naveed K Shams11
Rao Uppaluri11
Alice Lin-Tsing Yu11
Alice Lin-Tsing C. Yu11
Juan F. Rodriguez11
John A. Paganelli11
Robert A. Baron11

People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.